Contact Information
Company Information
Annual Revenue
25051000.0
Total Funding
176587765.0
Latest Funding
Debt Financing
Technologies
Outlook
Google Analytics
Mobile Friendly
Google Tag Manager
WordPress.org
Vimeo
Keywords
oncology
immuneevasive
axl
biotechnology research
antibody therapeutics
immuno-oncology
immune inflammatory diseases
antibody discovery
monoclonal antibodies
biologics
combination therapy
clinical development
protein characterization
drug conjugates
immunization regimens
antibody screening
high-affinity antibodies
bi-specific antibodies
early development
symplex technology
proprietary platforms
practical evidence
therapeutic innovation
scientific collaboration
patient health
healthcare access
immune system
disease-specific antigens
antibody functionality
pharmaceutical r&d
genomic sequencing
pharmaceutical development
quality assurance
pharmaceutical partnerships
preclinical studies
biomedical research
pharmaceutical manufacturing
gmp compliance
biotech solutions
cancer research
therapeutic effectiveness
biopharmaceutical industry
innovative therapies
antibody engineering
patient-focused solutions
therapeutic pipelines
research collaborations
product validation
therapeutic advancements
scientific expertise
pharmaceutical products
biotechnology
biopharmaceuticals
recombinant monoclonal antibodies
immune-oncology
therapeutic solutions
cancer treatment
immunoglobulin replacement
infectious diseases
drug discovery
antibody manufacturing
symplex platform
sympress platform
monoclonal antibody mixtures
combination therapies
patient outcomes
healthcare professionals
cancer patients
therapeutic antibodies
clinical trials
drug candidates
servier group
healthcare accessibility
patient needs
hospital & health care
pharmaceuticals
medical
health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans